Syneron Medical Ltd. - Ordinary Shares (delisted) (NASDAQ:ELOS)
Historical Stock Chart
5 Years : From Oct 2012 to Oct 2017
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Dominick Arena has been appointed to the Company's Board of Directors effective as of March 5, 2012. Mr. Arena has over 30 years of experience in the healthcare industry leading companies of various sizes and stages of development, from start-ups to large multinational companies. He replaces Jerry Puorro, who recently retired from the Board of Directors. Mr. Puorro was President and Chief Executive Officer of Candela Corporation prior to its acquisition by Syneron in January 2010. Following the appointment of Mr. Arena, Syneron continues to have six independent directors and one non-independent director.
Dr. Shimon Eckhouse, Co-founder and Chairman of the Board of Directors of Syneron Medical, said, "We are pleased to welcome Dominick Arena to the Syneron Board of Directors. Dominick has a proven track record as an executive in the healthcare industry, including a wide array of relevant experience that will benefit Syneron. This includes his current positions, which focus on providing strategic guidance in operational management, mergers and acquisitions, and developing and executing growth strategies. We look forward to working with Dominick as we continue to strive to enhance the value of the Company for our shareholders."
Dr. Eckhouse added, "On behalf of the Board of Directors, I would like to thank Jerry Puorro for his service on the Board. We benefitted from Jerry's strong industry experience and his significant contributions during the Candela integration process. We wish him the best in his other endeavors."
Mr. Arena currently serves as an operating partner with Water Street Healthcare Partners, a strategic private equity firm focused exclusively on the healthcare industry. Previously, Mr. Arena was President of Smiths Critical Care, a division of Smiths Medical. He joined Smiths Medical after the company acquired Medex Inc., where he served as President and Chief Executive Officer. Prior to this, Mr. Arena led the Healthcare division of the Furon Company, and served as the leader of three medical device manufacturers: AnaMed International, Hudson Respiratory Care, and Respiratory Care, Inc. He also previously held positions at The Kendall Corporation and Baxter International Inc. Mr. Arena currently serves on the Boards of Directors of Sigma International, US Endoscopy, and The Legacy Foundation. He previously served on the Boards of Alpine Biomed and Facet Technologies. Mr. Arena received a Bachelors of Science in Chemistry from Le Moyne College.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
Chief Financial Officer
+ 972 73 244 2283
Email: Email Contact
The Ruth Group
Email: Email Contact